Topoisomerase I | Drugs Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

29,501 results for “Topoisomerase I”

AM9-79

topoisomerase I inhibitors (cancer)

topoisomerase I inhibitor (sepsis)

topoisomerase I inhibitors (Albany Molecular Research)

anti- topoisomerase I bispecific antibody-drug conjugate (solid tumor)

HG-1317

dual acting DNA topoisomerase I/II inhibitors/apoptosis inducer (cancer)

anti-Liv-1 mAb/topoisomerase I Inhibitor ADC (Triple-negative breast cancer/solid tumor)

Epirubicin(Ellence, Pharmorubicin PFS)

Manufacturer: Pfizer inc, Actavis totowa llc +10 more

Conditions: Breast Cancer, Breast Cancer, Stage II +11 more

C₂₇H₂₉NO₁₁ · Rx

Investigational

Sacituzumab Govitecan(Trodelvy)

Conditions: Hormone Receptor Positive Metastatic Breast Cancer, Locally Advanced or Metastatic Urothelial Carcinoma (UC) +6 more

C₂₂H₂₀N₂O₅ · Rx

Page 1 of 63